Vaccines for children
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16112
- Awardee
-
Grifols USA LLC UEI D48FNWJCJ5H5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Children Solicitation · 75D30122R72514 · Posted Jan 18, 2023
- Last date to order 100% complete
- IDV ceiling
- $13,881,750.00
- Maximum order
- $13,881,638.94
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Grifols USA LLC, a large pharmaceutical manufacturer. The contract, valued at up to $13.88 million annually, is for the supply of a wide range of pediatric vaccines to support the CDC's Vaccines for Children (VFC) program. The vaccines include routine immunizations such as DTaP, Hib, hepatitis, and MMR, among others. The contract has a period of performance from April 1, 2023 through March 31, 2024.
The original solicitation did not use any set-aside designations, as the CDC sought to establish multiple award IDCs to ensure a reliable supply of these critical vaccines nationwide. Offerors were required to be FDA-licensed vaccine manufacturers able to provide 12-month minimum shelf lives and 15-day delivery to CDC depots. Evaluation criteria included past performance, electronic data interchange capabilities, and authorized distributor status. The vaccines will be shipped FOB destination to the 50 states and U.S. territories, with fixed pricing that includes applicable federal excise taxes. This recurring contract demonstrates Grifols' role in supporting federal healthcare initiatives through the consistent supply of essential pharmaceutical products.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$111 | |
| Supplemental Agreement for work within scope | $5,978 | |
| Funding Only Action | $713,503 | |
| Original award | $194,974 |
Quick answers
Who was awarded contract 75D30123D16112?
75D30123D16112 was awarded to Grifols USA LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2023.
How much is contract 75D30123D16112 worth?
75D30123D16112's own ceiling is $13,881,750. A single order can be worth up to $13,881,639.
Who can order from contract 75D30123D16112?
75D30123D16112 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16112 competed?
The extent of competition for 75D30123D16112 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV